Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88444372 |
LAW OFFICE ASSIGNED |
LAW OFFICE 108 |
MARK SECTION |
MARK FILE NAME |
http://uspto.report/TM/88444372/mark.png |
LITERAL ELEMENT |
SPARC |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
ARGUMENT(S) |
Thank you for your letter in connection with the above application. We write in response and to request reconsideration of the refusal to register
and to address an identification issue and offer the following arguments in support of registration. The Examining Attorney refused registration of the mark SPARC (serial no.: 88/444,372) for,
"medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical and health care services; consultancy and advisory services provided by
doctors, providing medical information and services in the field of health care, medicines, dietary substances, nutritions" (the "Applicant's Mark"), in International Class 044 on the basis that
Applicant's Mark is likely to be confused with: - U.S. Registration No.: 4,489,844 (SPARC MICROENVIRONMENT SIGNATURE (SMS)) for "Providing medical diagnostic testing and analysis to determine
appropriate therapy; Medical and pharmaceutical information services in the field of cancer; Medical and pharmaceutical consultation services in the field of cancer; Medical information and medical
consultation" in Class 044. For the reasons that follow, Sun Pharma Advanced Research Company Ltd. ("Applicant"), respectfully submits that the Applicant's Mark is not likely to be confused with the
Cited Mark because: (1) the Applicant's Mark is distinct; (2) and, customers of the goods and services are sophisticated. THE APPLICANT'S MARK IS DISTINCT In determining whether a mark is dissimilar
in its entirety as to appearance, sound, connotation and commercial impression, the proper test is "whether the marks are sufficiently similar in terms of their commercial impression such that
persons who encounter the marks would be likely to assume a connection between the parties." Coach Servs. Inc. v. Triumph Learning LLC, 101 USPQ2d 1713, 1721 (Fed. Cir. 2012). The proper test avoids
a "dissection" of the marks and instead "consider[s] the marks at issue in their entireties..." In re Colorbar Cosmetics Private Ltd., 2015 WL 7772721, Serial No. 86/323,815, at *6 (TTAB Nov. 20,
2015). The preliminary determination that SPARC is confusingly similar to the Cited Mark is based on a dissection of the Applicant's Mark. To that end, it is well established that "a mark should not
be dissected and considered piecemeal; rather, it must be considered as a whole in determining likelihood of confusion." Juice Generation, Inc. v. GS Enters. LLC, 794 F.3d 1334, 1340 (Fed. Cir.
2015); TMEP section 1207.01(b)(iv). Applicant submits that the Applicant's Mark was improperly dissected when the Examining Attorney concluded that: The marks are similar because the dominant
elements of both marks is the shared term "SPARC." While the Cited Mark and the Applicant's Mark contain the letters "SPARC," the Cited Mark includes not only the phrase "MICROENVIRONMENT SIGNATURE"
but also "(SMS)," both which are not featured in the Applicant's Mark. Thus, "SPARC" should not be dissected from the Cited Mark in assessing any similarity between the Applicant's Mark and the Cited
Mark. A comparison of the Applicant's Mark and the Cited Mark demonstrates that the Applicant's Mark even in just the word form is visually distinct, phonetically distinct, and creates a distinct
commercial impression, from the Cited Mark; and the actual mark as sought registration is even more visually distinct from the Cited Mark: Applicant's Mark In Word Form and As Applied Cited Mark
SPARC SPARC MICROENVIRONMENT SIGNATURE (SMS) Specifically, while the Applicant's Mark and the Cited Mark include letters, "SPARC," both Applicant's Mark and the Cited Mark contain other unique
distinguishing features. The unique distinguishing features are (for Applicant's Mark, the graphic) and for the Cited Mark, the addition of "MICROENVIRONMENT SIGNATURE" and "(SMS)." These unique
distinguishing features affect "the appearance and sound of the marks." In re Colorbar Cosmetics, 2015 WL 7772721, at*6 (reversing refusal to register and noting the distinguishing feature of "USA"
in COLORBAR USA to "The" in THE COLOR BAR). These unique distinguishing features demonstrate that the Cited Mark is visually dissimilar from the Applicant's Mark, making consumer confusion highly
unlikely. Citigroup Inc. v. Capital City Bank Group, Inc., 637 F.3d 1344, 1356, 98 USPQ2d 1253, 1261 (Fed. Cir. 2011) (affirming TTAB's holding that contemporaneous use of applicant's CAPITAL CITY
BANK marks for banking and financial services, and opposer's CITIBANK marks for banking and financial services, is not likely cause confusion); Shen Mfg. Co. v. Ritz Hotel Ltd., 393 F.3d 1238, 1245,
73 USPQ2d 1350, 1356-57 (Fed. Cir. 2004) (reversing TTAB's holding that contemporaneous use of THE RITZ KIDS and RITZ is likely to cause confusion, because, inter alia, THE RITZ KIDS creates a
different commercial impression). Further underscoring the distinct commercial impression created by the Applicant's Mark on the one hand and the Cited Mark on the other is the prominent phonetic
differences between the marks when reviewed as a whole. Due to this lack of aural similarity, there is no likelihood of confusion among consumers who speak or hear the Cited Mark and the Applicant's
Mark. The Examining Attorney also supports the likelihood of confusion determination by claiming that "SPARC" and "SPARC MICROENVIRONMENT SIGNATURE (SMS)" share a "common term that is purely
arbitrary." But all of the cases cited in support regard two single-word marks. See, e.g., Crocker Nat'l Bank v. Canadian Imperial Bank of Commerce, 228 U.S.P.Q. 689 (TTAB 1986) (COMMCASH and
COMMUNICASH), aff'd sub nom, Canadian Imperial Bank of Commerce v. Well Fargo Bank, Nat'l Ass'n, 811 F.2d 1490 (Fed. Cir. 1987); In re Corning Glass Works, 229 USPQ 65 (TTAB 1985) (CONFIRM and
CONFIRMCELLS); In re Pellerin Milnor Corp., 221 USPQ 558 (TTAB 1983) (MILTRON and MILLTRONICS). Here, Applicant's Mark is a design element and single word, SPARC, while the Cited Mark includes three
words plus three letters, SPARC MICROENVIRONMENT SIGNATURE (SMS). Thus, like the Ritz case, the contemporaneous use of SPARC in both marks is not likely to cause confusion because SPARC creates a
different commercial impression than does SPARC MICROENVIRONMENT SIGNATURE (SMS). See Ritz Hotel, 393 F.3d at 1245. Moreover, both marks here evoke different acronyms. For instance the Applicant's
Mark, SPARC, reflects Applicant's company name, Sun Pharma Advanced Research Company, while the Cited Mark uses its acronym within its mark, e.g., SPARC MICROENVIRONMENT SIGNATURE (SMS), the latter
is seemingly for Sparc Microenvironment Signature. These marks plainly do not convey a shared source. Further, Applicant's marketing and advertising, which highlights the reflection of an acronym in
its mark, SPARC, demonstrates that consumers would be familiar with Applicant's wording for which SPARC is an acronym. (See Exhibit 1, page from Applicant's website, located at:
http://www.sparc.life/who-we-are). THE MARKET IS HIGHLY SOPHISTICATED The market for the Applicant's goods and services is not the general consuming public, as the Examining Attorney suggests. To
be clear, "consumers" of Applicant's goods and services under the mark SPARC primarily are not members of the general public. To the contrary, Applicant primarily licenses and/or sells its goods and
services under the mark, SPARC, to corporate entities as potential partners for commercialization. (See Exhibit 2, Declaration of Craig Kuchii, Esq.). Thus, customers of Applicant's goods and
services are highly sophisticated purchasers, making it "highly unlikely that the respective goods would be encountered by the same purchasers under circumstances which could give rise to the
mistaken belief that such goods originate from a common source..." See In re NeoPhotonics Corp., 2008 WL 4572604, at *6 (TTAB Oct. 10, 2008). To be sure, there is "always less likelihood of confusion
where goods are" more costly and purchased by sophisticated consumers. See Astra Pharmaceutical Prods., Inc. v. Beckman Instruments, Inc., 718 F.2d 1201, 1205 (1st Cir. 1983). In fact, the TTAB has
regularly found no likelihood of confusion where the market is highly sophisticated such as it is here. For example, in a case where the marks were VIGILANZ for computer monitoring systems that
detect possible adverse drug events and VIGILANCE for heart monitors, the TTAB found both were used "in hospitals to monitor some aspect of patient care," but no likelihood of confusion, in part on
the basis that the goods are purchased by sophisticated purchasers as opposed to the general public. See Edwards Lifesciences Corp. v. VigiLanz Corp., 94 USPQ2d 1399 (TTAB 2010); see also In re
Digirad Corp., 45 USPQ2d 1841 (TTAB 1998) (finding no likelihood of confusion regarding DIGIRAD and DIGIRAY where both products are "in the general category of medical diagnostic equipment and are
used to diagnose diseases and abnormalities in the human body..."); see In re Invivo Corp., 2007 WL 2698307, at *6 (TTAB Sept. 5, 2007) (refusal to register reversed for TELEPAK where other mark was
TELEPAC and stating, "given the knowledge, care and deliberation required of doctors, hospitals and other medical institutions in making the purchasing decisions with respect to applicant and
registrant's goods, it is unlikely that they would be confused") (citing 3 McCarthy on Trademarks and Unfair Competition sections 23:95, 23:101 (4th ed. 1998) ("[w]here the relevant buyer class is
composed solely of professional, or commercial purchasers, it is reasonable to set a higher standard of care than for consumers"). Accordingly, the Examining Attorney's comments regarding consumers'
general inclinations with respect to focus on a mark are not applicable here because they are not Applicant's customers. Plus, the Examiner notes that the Cited Mark includes "medical diagnostic
services," which is not identified in Applicant's Mark at all. For the foregoing reasons, Applicant respectfully requests that the Examining Attorney reconsider the refusal to register as outlined in
the office action and thanks the Examining Attorney for consideration of the foregoing. REQUIREMENT - IDENTIFICATION The Examining Attorney has suggested an amendment to the Applicant's
identification. The current identification is: International Class 044: medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical
and health care services; consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances, nutritions. The
Examining Attorney has recommended the following Suggested Amendment: International Class 044: medical services, providing medical information about health issues, medical clinics, medical
assistance, and health care services; medical and health care consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, medicines,
dietary substances, and nutrition. Applicant appreciates the Examining Attorneys suggestions and accepts and agrees to the Examining Attorney's suggested amendment to the identification for
International Class 044, except Applicant seeks to further narrow that identification by deleting "cosmetics, dietary substances, and nutrition." Thus, Applicant suggests the following amendment to
the identification in International Class 044: International Class 044: medical services, providing medical information about health issues, medical clinics, medical assistance, and health care
services; medical and health care consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, and medicines. Applicant appreciates
the Examining Attorneys suggestions and in light of the fact that Applicant has agreed to delete the related references that previously were included in its International Class 044 identification as
shown by the agreed upon amendment, above, Applicant's amendments narrow the application and are believed to be acceptable. Please do not hesitate to contact me if you require any additional
information or documentation to assist in your review. Exhibit 1: http://www.sparc.life/who-we-are Exhibit 2: DECLARATION OF CRAIG KUCHII, ESQ. Trademark Application Serial No.: 88/444,348 (SPARC)
I, Craig Kuchii, Esq., make this Declaration under penalty of perjury as follows: 1. I am over the age of eighteen and competent to make this Declaration. The information contained in this
Declaration is based upon my investigation and discussions with persons with knowledge at Sun Pharma Advanced Research Company Ltd. ("Sparc"). 2. I serve as the Associate Vice President, Intellectual
Property, at Sparc, the applicant of record for trademark application serial no.: 88/444,348 for the trademark, SPARC. 3. I make this Declaration in support of Sparc's response to the Office Action
dated June 14, 2019. 4. Sparc is a company focused on research and development to develop drugs for unmet needs through innovations in therapeutics and in delivery. 5. Sparc primarily licenses and/or
sells its goods and services under the mark, SPARC, to corporate entities as potential partners for commercialization. The undersigned being warned that willful false statements and the like are
punishable by fine or imprisonment, or both, under 18 U.S.C. section 1001, and that such willful false statements and the like may jeopardize the validity of the application or document or any
registration resulting therefrom, declares that all statements made of his own knowledge are true; and all statements made on information and belief are believed to be true. /craig kuchii/ |
GOODS AND/OR SERVICES SECTION (current) |
INTERNATIONAL CLASS |
044 |
DESCRIPTION |
medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical and
health care services; consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances, nutritions |
FILING BASIS |
Section 44(e) |
FOREIGN REGISTRATION NUMBER |
3916800 |
FOREIGN REGISTRATION
COUNTRY |
India |
FOREIGN REGISTRATION
DATE |
08/14/2018 |
FOREIGN EXPIRATION DATE |
08/14/2028 |
DATE FOREIGN REGISTRATION
RENEWED
(if applicable) |
08/14/2028 |
GOODS AND/OR SERVICES SECTION (proposed) |
INTERNATIONAL CLASS |
044 |
TRACKED TEXT DESCRIPTION |
medical services, services relating to rendering information about health issues, medical clinics,
medical assistance, medical and health care services; medical services, providing medical information about health issues, medical clinics, medical assistance,
and health care services; consultancy and advisory services provided by doctors, providing medical information and services in the field of health care,
medicines, dietary substances, nutritions; medical and health care consultancy and advisory services provided by doctors, providing medical information and
services in the field of health care, and medicines |
FINAL DESCRIPTION |
medical services, providing medical information about health issues, medical clinics, medical assistance, and health care services;
medical and health care consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, and medicines |
FILING BASIS |
Section 44(e) |
FOREIGN REGISTRATION NUMBER |
3916800 |
FOREIGN REGISTRATION
COUNTRY |
India |
FOREIGN REGISTRATION
DATE |
08/14/2018 |
FOREIGN EXPIRATION DATE |
08/14/2028 |
DATE FOREIGN REGISTRATION
RENEWED
(if applicable) |
08/14/2028 |
ATTORNEY SECTION (current) |
NAME |
Craig Kuchii, Esq. |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
SUN PHARMACEUTICAL INDUSTRIES, INC. |
INTERNAL ADDRESS |
INTELLECTUAL PROPERTY DEPT. |
STREET |
2 INDEPENDENCE WAY |
CITY |
PRINCETON |
STATE |
New Jersey |
POSTAL CODE |
08540 |
COUNTRY |
US |
PHONE |
609-720-5394 |
EMAIL |
general.ip.mailbox@sunpharma.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
SPTM-044US |
ATTORNEY SECTION (proposed) |
NAME |
Craig Kuchii, Esq. |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
SUN PHARMACEUTICAL INDUSTRIES, INC. |
INTERNAL ADDRESS |
INTELLECTUAL PROPERTY DEPT. |
STREET |
2 INDEPENDENCE WAY |
CITY |
PRINCETON |
STATE |
New Jersey |
POSTAL CODE |
08540 |
COUNTRY |
United States |
PHONE |
609-720-5394 |
EMAIL |
general.ip.mailbox@sunpharma.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
SPTM-044US |
CORRESPONDENCE SECTION (current) |
NAME |
CRAIG KUCHII, ESQ. |
FIRM NAME |
SUN PHARMACEUTICAL INDUSTRIES, INC. |
INTERNAL ADDRESS |
INTELLECTUAL PROPERTY DEPT. |
STREET |
2 INDEPENDENCE WAY |
CITY |
PRINCETON |
STATE |
New Jersey |
POSTAL CODE |
08540 |
COUNTRY |
US |
PHONE |
609-720-5394 |
EMAIL |
general.ip.mailbox@sunpharma.com; brandprotection@sunpharma.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
SPTM-044US |
CORRESPONDENCE SECTION (proposed) |
NAME |
Craig Kuchii, Esq. |
FIRM NAME |
SUN PHARMACEUTICAL INDUSTRIES, INC. |
INTERNAL ADDRESS |
INTELLECTUAL PROPERTY DEPT. |
STREET |
2 INDEPENDENCE WAY |
CITY |
PRINCETON |
STATE |
New Jersey |
POSTAL CODE |
08540 |
COUNTRY |
United States |
PHONE |
609-720-5394 |
EMAIL |
general.ip.mailbox@sunpharma.com; brandprotection@sunpharma.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
SPTM-044US |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/craig kuchii/ |
SIGNATORY'S NAME |
Craig Kuchii |
SIGNATORY'S POSITION |
Associate VP, Intellectual Property |
SIGNATORY'S PHONE NUMBER |
609-720-5394 |
DATE SIGNED |
12/16/2019 |
AUTHORIZED SIGNATORY |
YES |
FILING INFORMATION SECTION |
SUBMIT DATE |
Mon Dec 16 22:37:06 EST 2019 |
TEAS STAMP |
USPTO/ROA-XX.XXX.XX.XX-20
191216223706106652-884443
72-70030771a27f5c755c7d14
fe959d74984aad414ac32cfb2
7b15c174d9a46c2e6-N/A-N/A
-20191216221721013860 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88444372 SPARC (Stylized and/or with Design, see http://uspto.report/TM/88444372/mark.png) has been amended as follows:
ARGUMENT(S)
In response to the substantive refusal(s), please note the following:
Thank you for your letter in connection with the above application. We write in response and to request reconsideration of the refusal to register and to address an identification issue and offer the
following arguments in support of registration. The Examining Attorney refused registration of the mark SPARC (serial no.: 88/444,372) for, "medical services, services relating to rendering
information about health issues, medical clinics, medical assistance, medical and health care services; consultancy and advisory services provided by doctors, providing medical information and
services in the field of health care, medicines, dietary substances, nutritions" (the "Applicant's Mark"), in International Class 044 on the basis that Applicant's Mark is likely to be confused with:
- U.S. Registration No.: 4,489,844 (SPARC MICROENVIRONMENT SIGNATURE (SMS)) for "Providing medical diagnostic testing and analysis to determine appropriate therapy; Medical and pharmaceutical
information services in the field of cancer; Medical and pharmaceutical consultation services in the field of cancer; Medical information and medical consultation" in Class 044. For the reasons that
follow, Sun Pharma Advanced Research Company Ltd. ("Applicant"), respectfully submits that the Applicant's Mark is not likely to be confused with the Cited Mark because: (1) the Applicant's Mark is
distinct; (2) and, customers of the goods and services are sophisticated. THE APPLICANT'S MARK IS DISTINCT In determining whether a mark is dissimilar in its entirety as to appearance, sound,
connotation and commercial impression, the proper test is "whether the marks are sufficiently similar in terms of their commercial impression such that persons who encounter the marks would be likely
to assume a connection between the parties." Coach Servs. Inc. v. Triumph Learning LLC, 101 USPQ2d 1713, 1721 (Fed. Cir. 2012). The proper test avoids a "dissection" of the marks and instead
"consider[s] the marks at issue in their entireties..." In re Colorbar Cosmetics Private Ltd., 2015 WL 7772721, Serial No. 86/323,815, at *6 (TTAB Nov. 20, 2015). The preliminary determination that
SPARC is confusingly similar to the Cited Mark is based on a dissection of the Applicant's Mark. To that end, it is well established that "a mark should not be dissected and considered piecemeal;
rather, it must be considered as a whole in determining likelihood of confusion." Juice Generation, Inc. v. GS Enters. LLC, 794 F.3d 1334, 1340 (Fed. Cir. 2015); TMEP section 1207.01(b)(iv).
Applicant submits that the Applicant's Mark was improperly dissected when the Examining Attorney concluded that: The marks are similar because the dominant elements of both marks is the shared term
"SPARC." While the Cited Mark and the Applicant's Mark contain the letters "SPARC," the Cited Mark includes not only the phrase "MICROENVIRONMENT SIGNATURE" but also "(SMS)," both which are not
featured in the Applicant's Mark. Thus, "SPARC" should not be dissected from the Cited Mark in assessing any similarity between the Applicant's Mark and the Cited Mark. A comparison of the
Applicant's Mark and the Cited Mark demonstrates that the Applicant's Mark even in just the word form is visually distinct, phonetically distinct, and creates a distinct commercial impression, from
the Cited Mark; and the actual mark as sought registration is even more visually distinct from the Cited Mark: Applicant's Mark In Word Form and As Applied Cited Mark SPARC SPARC MICROENVIRONMENT
SIGNATURE (SMS) Specifically, while the Applicant's Mark and the Cited Mark include letters, "SPARC," both Applicant's Mark and the Cited Mark contain other unique distinguishing features. The unique
distinguishing features are (for Applicant's Mark, the graphic) and for the Cited Mark, the addition of "MICROENVIRONMENT SIGNATURE" and "(SMS)." These unique distinguishing features affect "the
appearance and sound of the marks." In re Colorbar Cosmetics, 2015 WL 7772721, at*6 (reversing refusal to register and noting the distinguishing feature of "USA" in COLORBAR USA to "The" in THE COLOR
BAR). These unique distinguishing features demonstrate that the Cited Mark is visually dissimilar from the Applicant's Mark, making consumer confusion highly unlikely. Citigroup Inc. v. Capital City
Bank Group, Inc., 637 F.3d 1344, 1356, 98 USPQ2d 1253, 1261 (Fed. Cir. 2011) (affirming TTAB's holding that contemporaneous use of applicant's CAPITAL CITY BANK marks for banking and financial
services, and opposer's CITIBANK marks for banking and financial services, is not likely cause confusion); Shen Mfg. Co. v. Ritz Hotel Ltd., 393 F.3d 1238, 1245, 73 USPQ2d 1350, 1356-57 (Fed. Cir.
2004) (reversing TTAB's holding that contemporaneous use of THE RITZ KIDS and RITZ is likely to cause confusion, because, inter alia, THE RITZ KIDS creates a different commercial impression). Further
underscoring the distinct commercial impression created by the Applicant's Mark on the one hand and the Cited Mark on the other is the prominent phonetic differences between the marks when reviewed
as a whole. Due to this lack of aural similarity, there is no likelihood of confusion among consumers who speak or hear the Cited Mark and the Applicant's Mark. The Examining Attorney also supports
the likelihood of confusion determination by claiming that "SPARC" and "SPARC MICROENVIRONMENT SIGNATURE (SMS)" share a "common term that is purely arbitrary." But all of the cases cited in support
regard two single-word marks. See, e.g., Crocker Nat'l Bank v. Canadian Imperial Bank of Commerce, 228 U.S.P.Q. 689 (TTAB 1986) (COMMCASH and COMMUNICASH), aff'd sub nom, Canadian Imperial Bank of
Commerce v. Well Fargo Bank, Nat'l Ass'n, 811 F.2d 1490 (Fed. Cir. 1987); In re Corning Glass Works, 229 USPQ 65 (TTAB 1985) (CONFIRM and CONFIRMCELLS); In re Pellerin Milnor Corp., 221 USPQ 558
(TTAB 1983) (MILTRON and MILLTRONICS). Here, Applicant's Mark is a design element and single word, SPARC, while the Cited Mark includes three words plus three letters, SPARC MICROENVIRONMENT
SIGNATURE (SMS). Thus, like the Ritz case, the contemporaneous use of SPARC in both marks is not likely to cause confusion because SPARC creates a different commercial impression than does SPARC
MICROENVIRONMENT SIGNATURE (SMS). See Ritz Hotel, 393 F.3d at 1245. Moreover, both marks here evoke different acronyms. For instance the Applicant's Mark, SPARC, reflects Applicant's company name,
Sun Pharma Advanced Research Company, while the Cited Mark uses its acronym within its mark, e.g., SPARC MICROENVIRONMENT SIGNATURE (SMS), the latter is seemingly for Sparc Microenvironment
Signature. These marks plainly do not convey a shared source. Further, Applicant's marketing and advertising, which highlights the reflection of an acronym in its mark, SPARC, demonstrates that
consumers would be familiar with Applicant's wording for which SPARC is an acronym. (See Exhibit 1, page from Applicant's website, located at: http://www.sparc.life/who-we-are). THE MARKET IS
HIGHLY SOPHISTICATED The market for the Applicant's goods and services is not the general consuming public, as the Examining Attorney suggests. To be clear, "consumers" of Applicant's goods and
services under the mark SPARC primarily are not members of the general public. To the contrary, Applicant primarily licenses and/or sells its goods and services under the mark, SPARC, to corporate
entities as potential partners for commercialization. (See Exhibit 2, Declaration of Craig Kuchii, Esq.). Thus, customers of Applicant's goods and services are highly sophisticated purchasers, making
it "highly unlikely that the respective goods would be encountered by the same purchasers under circumstances which could give rise to the mistaken belief that such goods originate from a common
source..." See In re NeoPhotonics Corp., 2008 WL 4572604, at *6 (TTAB Oct. 10, 2008). To be sure, there is "always less likelihood of confusion where goods are" more costly and purchased by
sophisticated consumers. See Astra Pharmaceutical Prods., Inc. v. Beckman Instruments, Inc., 718 F.2d 1201, 1205 (1st Cir. 1983). In fact, the TTAB has regularly found no likelihood of confusion
where the market is highly sophisticated such as it is here. For example, in a case where the marks were VIGILANZ for computer monitoring systems that detect possible adverse drug events and
VIGILANCE for heart monitors, the TTAB found both were used "in hospitals to monitor some aspect of patient care," but no likelihood of confusion, in part on the basis that the goods are purchased by
sophisticated purchasers as opposed to the general public. See Edwards Lifesciences Corp. v. VigiLanz Corp., 94 USPQ2d 1399 (TTAB 2010); see also In re Digirad Corp., 45 USPQ2d 1841 (TTAB 1998)
(finding no likelihood of confusion regarding DIGIRAD and DIGIRAY where both products are "in the general category of medical diagnostic equipment and are used to diagnose diseases and abnormalities
in the human body..."); see In re Invivo Corp., 2007 WL 2698307, at *6 (TTAB Sept. 5, 2007) (refusal to register reversed for TELEPAK where other mark was TELEPAC and stating, "given the knowledge,
care and deliberation required of doctors, hospitals and other medical institutions in making the purchasing decisions with respect to applicant and registrant's goods, it is unlikely that they would
be confused") (citing 3 McCarthy on Trademarks and Unfair Competition sections 23:95, 23:101 (4th ed. 1998) ("[w]here the relevant buyer class is composed solely of professional, or commercial
purchasers, it is reasonable to set a higher standard of care than for consumers"). Accordingly, the Examining Attorney's comments regarding consumers' general inclinations with respect to focus on a
mark are not applicable here because they are not Applicant's customers. Plus, the Examiner notes that the Cited Mark includes "medical diagnostic services," which is not identified in Applicant's
Mark at all. For the foregoing reasons, Applicant respectfully requests that the Examining Attorney reconsider the refusal to register as outlined in the office action and thanks the Examining
Attorney for consideration of the foregoing. REQUIREMENT - IDENTIFICATION The Examining Attorney has suggested an amendment to the Applicant's identification. The current identification is:
International Class 044: medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical and health care services; consultancy and
advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances, nutritions. The Examining Attorney has recommended the
following Suggested Amendment: International Class 044: medical services, providing medical information about health issues, medical clinics, medical assistance, and health care services; medical and
health care consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances, and nutrition. Applicant
appreciates the Examining Attorneys suggestions and accepts and agrees to the Examining Attorney's suggested amendment to the identification for International Class 044, except Applicant seeks to
further narrow that identification by deleting "cosmetics, dietary substances, and nutrition." Thus, Applicant suggests the following amendment to the identification in International Class 044:
International Class 044: medical services, providing medical information about health issues, medical clinics, medical assistance, and health care services; medical and health care consultancy and
advisory services provided by doctors, providing medical information and services in the field of health care, and medicines. Applicant appreciates the Examining Attorneys suggestions and in light of
the fact that Applicant has agreed to delete the related references that previously were included in its International Class 044 identification as shown by the agreed upon amendment, above,
Applicant's amendments narrow the application and are believed to be acceptable. Please do not hesitate to contact me if you require any additional information or documentation to assist in your
review. Exhibit 1: http://www.sparc.life/who-we-are Exhibit 2: DECLARATION OF CRAIG KUCHII, ESQ. Trademark Application Serial No.: 88/444,348 (SPARC) I, Craig Kuchii, Esq., make this Declaration
under penalty of perjury as follows: 1. I am over the age of eighteen and competent to make this Declaration. The information contained in this Declaration is based upon my investigation and
discussions with persons with knowledge at Sun Pharma Advanced Research Company Ltd. ("Sparc"). 2. I serve as the Associate Vice President, Intellectual Property, at Sparc, the applicant of record
for trademark application serial no.: 88/444,348 for the trademark, SPARC. 3. I make this Declaration in support of Sparc's response to the Office Action dated June 14, 2019. 4. Sparc is a company
focused on research and development to develop drugs for unmet needs through innovations in therapeutics and in delivery. 5. Sparc primarily licenses and/or sells its goods and services under the
mark, SPARC, to corporate entities as potential partners for commercialization. The undersigned being warned that willful false statements and the like are punishable by fine or imprisonment, or
both, under 18 U.S.C. section 1001, and that such willful false statements and the like may jeopardize the validity of the application or document or any registration resulting therefrom, declares
that all statements made of his own knowledge are true; and all statements made on information and belief are believed to be true. /craig kuchii/
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 044 for medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical and health care services; consultancy and
advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances, nutritions
Original Filing Basis:
Filing Basis: Section 44(e), Based on Foreign Registration: For all applications: The applicant attaches a copy of [ India registration number 3916800 registered 08/14/2018 with
a renewal date of 08/14/2028 and an expiration date of 08/14/2028 ], and translation thereof, if appropriate.
For a trademark or service mark application: As of the application filing
date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services.
For a collective trademark, collective
service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the
use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the
application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users on or in connection with
the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the
certification program or of the goods or services that meet the certification standards of the applicant.
Proposed:
Tracked Text Description: medical services, services relating to rendering information about health issues, medical clinics, medical assistance, medical and
health care services;
medical services, providing medical information about health issues, medical clinics, medical assistance, and health care services;
consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, medicines, dietary substances,
nutritions;
medical and health care consultancy and advisory services provided by doctors, providing medical information and services in the field of health
care, and medicinesClass 044 for medical services, providing medical information about health issues, medical clinics, medical assistance, and health care services; medical and health care
consultancy and advisory services provided by doctors, providing medical information and services in the field of health care, and medicines
Filing Basis: Section 44(e), Based on Foreign Registration:For all applications: The applicant attaches a copy of [ India registration number 3916800 registered 08/14/2018 with a
renewal date of 08/14/2028 and an expiration date of 08/14/2028 ], and translation thereof, if appropriate, before the application may proceed to registration.
For a trademark or service mark
application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services.
For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization.
For a
certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in
commerce by authorized users on or in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is
applied, except to advertise or promote recognition of the certification program or of the goods or services that meet the certification standards of the applicant.
The applicant's current attorney information: Craig Kuchii, Esq.. Craig Kuchii, Esq. of SUN PHARMACEUTICAL INDUSTRIES, INC., is located at
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
US
The docket/reference number is SPTM-044US.
The phone number is 609-720-5394.
The email address is general.ip.mailbox@sunpharma.com
The applicants proposed attorney information: Craig Kuchii, Esq.. Craig Kuchii, Esq. of SUN PHARMACEUTICAL INDUSTRIES, INC., is a member of the XX bar, admitted to the bar in XXXX, bar
membership no. XXX, is located at
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
United States
The docket/reference number is SPTM-044US.
The phone number is 609-720-5394.
The email address is general.ip.mailbox@sunpharma.com
Craig Kuchii, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current correspondence information: CRAIG KUCHII, ESQ.. CRAIG KUCHII, ESQ. of SUN PHARMACEUTICAL INDUSTRIES, INC., is located at
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
US
The docket/reference number is SPTM-044US.
The phone number is 609-720-5394.
The email address is general.ip.mailbox@sunpharma.com; brandprotection@sunpharma.com
The applicants proposed correspondence information: Craig Kuchii, Esq.. Craig Kuchii, Esq. of SUN PHARMACEUTICAL INDUSTRIES, INC., is located at
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
United States
The docket/reference number is SPTM-044US.
The phone number is 609-720-5394.
The email address is general.ip.mailbox@sunpharma.com; brandprotection@sunpharma.com
SIGNATURE(S)
Response Signature
Signature: /craig kuchii/ Date: 12/16/2019
Signatory's Name: Craig Kuchii
Signatory's Position: Associate VP, Intellectual Property
Signatory's Phone Number: 609-720-5394
The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and
any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another
U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed
revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter;
or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.
Mailing Address: CRAIG KUCHII, ESQ.
SUN PHARMACEUTICAL INDUSTRIES, INC.
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
Mailing Address: Craig Kuchii, Esq.
SUN PHARMACEUTICAL INDUSTRIES, INC.
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON, New Jersey 08540
Serial Number: 88444372
Internet Transmission Date: Mon Dec 16 22:37:06 EST 2019
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XX-20191216223706106
652-88444372-70030771a27f5c755c7d14fe959
d74984aad414ac32cfb27b15c174d9a46c2e6-N/
A-N/A-20191216221721013860